About GlykoGen
glykogen aims to develop a pipeline of anti-glycan antibodies to target specific, currently ‘hard to treat’ cancers, including pancreatic cancer, using an innovative and patentable p... Read more
glykogen aims to develop a pipeline of anti-glycan antibodies to target specific, currently ‘hard to treat’ cancers, including pancreatic cancer, using an innovative and patentable p... Read more